The newly licensed platform enables precise control over both the drug-to-antibody ratio and payload attachment sites in single- and dual-payload ADCs
The acquisition marks Anupam Rasayan’s strategic entry into the pharmaceutical formulations segment
Sheshadri brings with him extensive leadership experience spanning healthcare, diagnostics, telecom, and consumer goods industries
Gambhir brings over 35 years of rich experience in strategic finance, governance, business transformation, and leadership
The study is being conducted through its Japan-based pharmaceutical arm, Asahi Kasei Therapeutics Corp
The deal the group says marks a decisive push deeper into severe infectious diseases and the build-out of a global specialty pharmaceuticals platform
A brand from Opella will be part of the official NASA astronaut formulary
The collaboration highlights the rising importance of intranasal delivery in developing non-vaccine approaches to respiratory disease prevention
The Flonase Allergy Relief Nasal Spray, 50 mcg per spray market achieved annual sales of approximately $384.7 million
These upgrades will enable advanced development and flexible manufacturing, supporting complex therapeutics and meeting global demand for advanced pharmaceutical solutions
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
